{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:35:04Z","timestamp":1793385304249,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":2607,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["5U10-CA11488-18S2"],"award-info":[{"award-number":["5U10-CA11488-18S2"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["5U10-CA11488-38"],"award-info":[{"award-number":["5U10-CA11488-38"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1093\/annonc\/mds065","type":"journal-article","created":{"date-parts":[[2012,4,8]],"date-time":"2012-04-08T03:44:31Z","timestamp":1333856671000},"page":"2708-2714","source":"Crossref","is-referenced-by-count":271,"title":["Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891"],"prefix":"10.1016","volume":"23","author":[{"given":"J.-L.","family":"Lefebvre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Andry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Luboinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Collette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Traissac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"de Raucourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1093\/annonc\/mds065_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9610(82)90419-6","article-title":"Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer","volume":"144","author":"Weaver","year":"1982","journal-title":"Am J Surg"},{"issue":"3","key":"10.1093\/annonc\/mds065_bb0015","first-page":"471","article-title":"Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck","volume":"66","author":"Kish","year":"1982","journal-title":"Cancer Treat Rep"},{"issue":"5","key":"10.1093\/annonc\/mds065_bb0020","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/1097-0142(19840901)54:5<811::AID-CNCR2820540508>3.0.CO;2-E","article-title":"Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck","volume":"54","author":"Ensley","year":"1984","journal-title":"Cancer"},{"issue":"13","key":"10.1093\/annonc\/mds065_bb0025","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group","volume":"88","author":"Lefebvre","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mds065_bb0030","author":"American Joint Committee on Cancer. TNM, Manual for Staging of Cancer","year":"1988"},{"key":"10.1093\/annonc\/mds065_bb0035","series-title":"WHO Handbook for Reporting Results of Cancer Treatment","author":"World Health Organization","year":"1979"},{"issue":"1","key":"10.1093\/annonc\/mds065_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2529712","article-title":"Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial","volume":"31","author":"Pocock","year":"1975","journal-title":"Biometrics"},{"issue":"14","key":"10.1093\/annonc\/mds065_bb0045","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/sim.4780121407","article-title":"How to establish equivalence when data are censored: a randomized trial of treatments for B non-Hodgkin lymphoma","volume":"12","author":"Com-Nougue","year":"1993","journal-title":"Stat Med"},{"issue":"3","key":"10.1093\/annonc\/mds065_bb0050","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"issue":"2","key":"10.1093\/annonc\/mds065_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomized controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1093\/annonc\/mds065_bb0060","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"31","key":"10.1093\/annonc\/mds065_bb0065","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J Clin Onol"},{"issue":"1","key":"10.1093\/annonc\/mds065_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hed.21406","article-title":"Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx","volume":"33","author":"Daly","year":"2011","journal-title":"Head Neck"},{"issue":"9208","key":"10.1093\/annonc\/mds065_bb0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mds065_bb0080","series-title":"In ASCO Annual Meeting of the Journal of Clinical Oncology (Abstr 5505)","article-title":"Update of the MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy","author":"Bourhis","year":"2004"},{"issue":"22","key":"10.1093\/annonc\/mds065_bb0085","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"issue":"18S","key":"10.1093\/annonc\/mds065_bb0090","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1200\/jco.2006.24.18_suppl.5517","article-title":"Long-term results of Intergroup RTOG 91\u201311: a phase III trial to preserve the larynx\u2013induction cisplatin\/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy","volume":"24","author":"Forasti\u00e8re","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds065_bb0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/djn460","article-title":"Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy","volume":"101","author":"Lefebvre","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mds065_bb0100","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation","volume":"101","author":"Pointreau","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mds065_bb0105","article-title":"Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of the head and neck: a phase III study of high dose radiation therapy with or without cetuximab","author":"Bonner","year":"2004","journal-title":"In ASCO Annual Meeting (Abstr 5507)"},{"key":"10.1093\/annonc\/mds065_bb0110","article-title":"Improved preservation of the larynx with the addition of cetuximab to radiation for cancers of the larynx and hypopharynx","author":"Bonner","year":"2005","journal-title":"In ASCO Annual Meeting (Abstr 5533)"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419379542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419379542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/10\/2708\/13786716\/mds065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:25:19Z","timestamp":1624519519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419379542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0923753419379542"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds065","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}